Detail page

Knowledge Web

Person

Elke Neumann-Haefelin (1976-)

Internistin

Name	Elke Neumann-Haefelin
Time	1976- (Date of birth and death)
Place	Tübingen (Geburtsort) Deutschland
Academic degree	Dr. med. (Univ. Freiburg (Breisgau)) (2003)
Profession	Internistin (characteristic profession) Nephrologin
Variant	Elke Caroline Neumann-Haefelin Elke Neumann- Haefelin Elke Schaffitzel (früherer Name)
Further information	Habil. Department für Innere Medizin der Univ. Freiburg (Breisgau)
Record type	Person
GND-Identifier	124676464
Record ID	124676464
Involved in show all Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors – a retrospective single center analysis Analysis of VHL-dependent SCD5 regulation and its biological function in clear cell renal cell carcinoma cells Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysis Genotype-specific neoplastic risk profiles in patients with VHL disease Intraoperative indocyanine green (ICG) videoangiography in spinal hemangioblastoma surgery - helpful tool or unnecessary? Nonstop mutations cause loss of renal tumor suppressor proteins VHL and BAP1 and affect multiple stages of protein translation Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zone Regulation von fat-7/SCD5 durch den Tumorsuppressor von Hippel-Lindau und Zusammenhang mit dem Fettstoffwechsel im klarzelligen Nierenzellkarzinom Saturation genome editing maps the functional spectrum of pathogenic VHL alleles Einfluss des VHL-1-HIF-1-Signalweges auf die Widerstandsfähigkeit von Caenorhabditis elegans gegenüber endoplasmatisch-retikulärem Stress Saturation genome editing maps the functional spectrum of pathogenic VHL alleles Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease Surveillance in children and adolescents with von Hippel-Lindau (VHL)-related pheochromocytomas and paragangliomas: a survey of MET and Freiburg-VHL registries in Germany Vhl and Rassf1a mutation causes replication stress, DNA damage and chromosomal instability Vhl and Rassf1a mutation causes replication stress, DNA damage and chromosomal instability VHL-dependence of EHHADH expression in a human renal cell carcinoma cell line Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study Der Einfluss der Lungenfunktion auf autolog transplantierte Patienten mit Multiplem Myelom Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study Integrated metabolomic and transcriptomic analysis of modified nucleosides for biomarker discovery in clear cell renal cell carcinoma SCD5 regulation by VHL affects cell proliferation and lipid homeostasis in ccRCC Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient vhl-1 beeinflusst osmotische und oxidative Stressantwort in C. elegans Rituximab als remissionserhaltende Therapie bei ANCA-assoziierter Vaskulitis Stereotactic body radiotherapy for renal cell carcinoma in patients with von Hippel–Lindau disease - results of a prospective trial Untersuchung der Interaktion von pVHL und Histondeacetylasen sowie der regulierenden Wirkung der Acetyltransferase p300 auf den Transkriptionsfaktor NRF2 Analyse der Interaktion des Tumorsuppressors VHL mit RAPTOR, der zentralen regulatorischen Untereinheit des mTORC1 Komplex Genotype–phenotype correlation in von Hippel‐Lindau disease Ift88, but not Kif3a, is required for establishment of the periciliary membrane compartment VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment Subcutaneous enoxaparin safely facilitates bedside sustained low-efficiency hemodialysis in hypercoagulopathic Coronavirus disease 2019 patients - proof-of-principle trial The acetyltransferase p300 regulates NRF2 stability and localization CBP-1/p300 acetyltransferase regulates SKN-1/Nrf cellular levels, nuclear localization, and activity in C. elegans Treating C3 glomerulopathy with eculizumab CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in C. elegans Treating C3 glomerulopathy with eculizumab Der Einfluss von Zellzyklusregulatoren auf die Entwicklung, Gesundheit und Lebensdauer von C. elegans Die Zellzyklusfaktoren CYE-1 und CDK-2 regulieren Stressantwort und Lebensdauer in C. elegans OSM-11 antagonizes SKN-1 in mesendodermal development and adult longevity and stress response in Caenorhabditis elegans Successful management of calciphylaxis in a kidney transplant patient: case report C. elegans als Modellsystem für Alterungsprozesse und Nierenerkrankungen Cell-nonautonomous signaling of FOXO/DAF-16 to the stem cells of Caenorhabditis elegans Binding specificity of Escherichia coli trigger factor Functional dissection of trigger factor and DnaK : interactions with nascent polypeptides and thermally denatured proteins Trigger Factor and DnaK possess overlapping substrate pools and binding specificities In-vitro-Analysen der Interaktion von Chaperonen mit naszierenden Polypeptidketten In-vitro-Analysen der Interaktion von Chaperonen mit naszierenden Polypeptidketten Functional Dissection of Trigger Factor and DnaK: Interactions with Nascent Polypeptides and Thermally Denatured Proteins

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Elke Neumann-Haefelin (1976-)

Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors – a retrospective single center analysis

Analysis of VHL-dependent SCD5 regulation and its biological function in clear cell renal cell carcinoma cells

Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysis

Genotype-specific neoplastic risk profiles in patients with VHL disease

Intraoperative indocyanine green (ICG) videoangiography in spinal hemangioblastoma surgery - helpful tool or unnecessary?

Nonstop mutations cause loss of renal tumor suppressor proteins VHL and BAP1 and affect multiple stages of protein translation

Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zone

Regulation von fat-7/SCD5 durch den Tumorsuppressor von Hippel-Lindau und Zusammenhang mit dem Fettstoffwechsel im klarzelligen Nierenzellkarzinom

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles

Einfluss des VHL-1-HIF-1-Signalweges auf die Widerstandsfähigkeit von Caenorhabditis elegans gegenüber endoplasmatisch-retikulärem Stress

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles

Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease

Surveillance in children and adolescents with von Hippel-Lindau (VHL)-related pheochromocytomas and paragangliomas: a survey of MET and Freiburg-VHL registries in Germany

Vhl and Rassf1a mutation causes replication stress, DNA damage and chromosomal instability

Vhl and Rassf1a mutation causes replication stress, DNA damage and chromosomal instability

VHL-dependence of EHHADH expression in a human renal cell carcinoma cell line

Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study

Der Einfluss der Lungenfunktion auf autolog transplantierte Patienten mit Multiplem Myelom

Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study

Integrated metabolomic and transcriptomic analysis of modified nucleosides for biomarker discovery in clear cell renal cell carcinoma

SCD5 regulation by VHL affects cell proliferation and lipid homeostasis in ccRCC

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient

vhl-1 beeinflusst osmotische und oxidative Stressantwort in C. elegans

Rituximab als remissionserhaltende Therapie bei ANCA-assoziierter Vaskulitis

Stereotactic body radiotherapy for renal cell carcinoma in patients with von Hippel–Lindau disease - results of a prospective trial

Untersuchung der Interaktion von pVHL und Histondeacetylasen sowie der regulierenden Wirkung der Acetyltransferase p300 auf den Transkriptionsfaktor NRF2

Analyse der Interaktion des Tumorsuppressors VHL mit RAPTOR, der zentralen regulatorischen Untereinheit des mTORC1 Komplex

Genotype–phenotype correlation in von Hippel‐Lindau disease

Ift88, but not Kif3a, is required for establishment of the periciliary membrane compartment

VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma

Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study

Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment

Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study

Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment

Subcutaneous enoxaparin safely facilitates bedside sustained low-efficiency hemodialysis in hypercoagulopathic Coronavirus disease 2019 patients - proof-of-principle trial

The acetyltransferase p300 regulates NRF2 stability and localization

CBP-1/p300 acetyltransferase regulates SKN-1/Nrf cellular levels, nuclear localization, and activity in C. elegans

Treating C3 glomerulopathy with eculizumab

CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in C. elegans

Treating C3 glomerulopathy with eculizumab

Der Einfluss von Zellzyklusregulatoren auf die Entwicklung, Gesundheit und Lebensdauer von C. elegans

Die Zellzyklusfaktoren CYE-1 und CDK-2 regulieren Stressantwort und Lebensdauer in C. elegans

OSM-11 antagonizes SKN-1 in mesendodermal development and adult longevity and stress response in Caenorhabditis elegans

Successful management of calciphylaxis in a kidney transplant patient: case report

C. elegans als Modellsystem für Alterungsprozesse und Nierenerkrankungen

Cell-nonautonomous signaling of FOXO/DAF-16 to the stem cells of Caenorhabditis elegans

Binding specificity of Escherichia coli trigger factor

Functional dissection of trigger factor and DnaK : interactions with nascent polypeptides and thermally denatured proteins

Trigger Factor and DnaK possess overlapping substrate pools and binding specificities

In-vitro-Analysen der Interaktion von Chaperonen mit naszierenden Polypeptidketten

In-vitro-Analysen der Interaktion von Chaperonen mit naszierenden Polypeptidketten

Functional Dissection of Trigger Factor and DnaK: Interactions with Nascent Polypeptides and Thermally Denatured Proteins